Replies to post #17212 on PharmaCyte Biotech Inc (PMCB)

[styl]

I understand what you mean.....


and in that aspect of less dilution I DO AGREE with you,,,,




But on a marketing standpoint and BRANDING of a company............the same way they paid for the trademark "cell in a box" from sg austria ........ It would have looked more professional to operate under a Biotechs name rather than a failed skin care product company who unfortunately has a history of failed products, thus giving shorts ammunition to paint us in a shady picture....thats all i am saying.

Not the best Marketing stand point to be doing this under Nuvilex..............to be honest they could have taken the easier route and do this under their already lisenced Medical marijuana Sciences subsidiary..........and with that name alone we might already be around 80 cents by now........

Just my opinion.

All in all .....in the long run it wont really matter Once they prove <i hope> the same results for fda approval

[styl]

i'm glad we own 15% of sg austria at least.

sounds like they will be having more things coming down their pipeline and when this company finally goes public 2 or 3 years from now this can add some impressive added value to this company.


Its amazing how this company Nuvilex is coming out of nowhere with cell in a box fda phase 3 trials..........15% ownership in sgaustria which may or may not go public in the future........and a subsidiary <medical marijuana sciences> with lots of promise as thc in marijuana is recognized as the medicine and cancer killer that it is.....<research hemp oil/rick simpson>.........

all this from what could be looked at as a startup.........but operating a strategy like a parent company with lots of potential.


OHHH.....lets not forget lots of funding of upto 27 million to keep them going til this strategy pays off in HUGE revenue and profits sure to come.